Capula Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Capula Management's GILD Position: Q2 2026 in Review
Capula Management opened a new position in Gilead Sciences (GILD) in Q2 2026: 1,147 shares worth $145K. The stake represents ﹤0.01% of the portfolio and ranks #580 among its holdings. This is a return to the name: Capula Management previously reported a position in GILD as recently as Q3 2025.
Capula Management first reported a position in GILD in Q3 2019 and has held it in 17 quarters since. The position peaked at $7.97M in Q3 2020. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Capula Management held 1,147 shares of Gilead Sciences worth $145K as of Q2 2026.
- Gilead Sciences was a new Capula Management position in Q2 2026.
- Gilead Sciences made up ﹤0.01% of Capula Management's portfolio in Q2 2026, its #580 holding.
- Capula Management first reported a position in Gilead Sciences in Q3 2019 and has held it in 17 quarters since.
- Capula Management's Gilead Sciences position peaked at $7.97M in Q3 2020.
- 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Capula Management's 13F filing for Q2 2026, filed 14 Aug 2026.